NEUROPSYCHIATRIC DISEASE AND TREATMENT (ONLINE)

Visão geral
Metrics
Identidade
Informação adicional documento
Ver todos

Qualis

A3

código do país

NZ

tipo

journal

publicação venue de

Comparison of Noninvasive Measurements of Intracranial with Tap Test Results in Patients with Idiopathic Normal Pressure Hydrocephalus. Volume 19:1127-1143. 2023-01-01
Systematic Review on EEG Analysis to Diagnose and Treat Autism by Evaluating Functional Connectivity and Spectral Power. Volume 19:415-424. 2023-01-01
Assessing the Capabilities of Transcranial Magnetic Stimulation (TMS) to Aid in the Removal of Brain Tumors Affecting the Motor Cortex: A Systematic Review. Volume 18:1219-1235. 2022-01-01
Bevacizumab for the Treatment of High-Grade Meningiomas: Is There New Evidence? [Letter]. Volume 18:2453-2454. 2022-01-01
Elevated Serum Complement C1q Levels After Traumatic Brain Injury [Letter]. Volume 18:951-952. 2022-01-01
Incidence of Postoperative Cognitive Dysfunction Following Inhalational vs Total Intravenous General Anesthesia: A Systematic Review and Meta-Analysis. Volume 18:1455-1467. 2022-01-01
Neurological Side Effects of SARS-CoV-2 Vaccinations are Not Uncommon but Frequently Ignored [Letter]. Volume 18:1273-1275. 2022-01-01
The CYP2C19*2 and CYP2C19*17 Polymorphisms Influence Responses to Clozapine for the Treatment of Schizophrenia
. Volume 16:427-432. 2020-01-01
Transcranial Direct Current Stimulation in Patients with Anxiety: Current Perspectives
. 2020:161-169. 2020-01-01
Treatment of Patients with Recently Exacerbated Schizophrenia with Paliperidone Palmitate: A Pilot Study of Efficacy and Tolerability
. Volume 16:2063-2072. 2020-01-01
The CYP2C19*2 and CYP2C19*17 Polymorphisms Influence Responses to Clozapine for the Treatment of Schizophrenia.. 16:427-432. 2020-01-01

tem uma área de assunto

publisher

Dove Medical Press

is open access

True invalid format

is in DOAJ

True invalid format